U.S. Professional Services Stock News

NYSE:RDN
NYSE:RDNDiversified Financial

Radian Group (RDN) Valuation Check After Mixed Recent Returns And 13.2% Undervaluation Estimate

Why Radian Group Is On Investors’ Radar Today Radian Group (RDN) is back in focus after recent trading left the stock at US$33.56, with returns mixed across different time frames, including a small gain over the past year but declines month to date and year to date. See our latest analysis for Radian Group. Recent trading has been choppy, with a 7 day share price return of 2.01%, a 30 day share price return of 5.86%, and a year to date share price return of 6.57%. Longer term total...
NasdaqGS:LBRD.K
NasdaqGS:LBRD.KMedia

Assessing Liberty Broadband (LBRD.K) Valuation After Swing To US$2.676b Full Year Loss

Earnings shock and what it means for Liberty Broadband stock Liberty Broadband (LBRD.K) just posted full year 2025 results showing a net loss of US$2.676b, compared with net income of US$869m in 2024, putting its shift in profitability squarely in focus for investors. See our latest analysis for Liberty Broadband. The earnings announcement has landed after a period where the 1 day share price return of 3.34% and 7 day share price return of 11.74% lifted the stock to US$53.76. However, the 1...
NYSE:QGEN
NYSE:QGENLife Sciences

Assessing Qiagen (QGEN) Valuation After Recent Share Price Momentum And Modest Undervaluation Estimate

What Qiagen (QGEN) offers and how the business makes money Qiagen (QGEN) focuses on what it calls sample to insight solutions, essentially turning raw biological material into molecular data that labs and clinicians can use in testing and research. The company generates revenue from a wide mix of consumables, instruments, and software used in molecular diagnostics, academic research, pharmaceutical development, and applied testing such as forensics and food safety. On the consumables side,...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

Assessing SS&C Technologies (SSNC) Valuation After Q4 Earnings Beat And Optimistic Guidance

SS&C Technologies Holdings (SSNC) is back in focus after reporting fourth quarter 2025 results that topped analyst expectations, paired with upbeat guidance and fresh client wins that point to ongoing business momentum. See our latest analysis for SS&C Technologies Holdings. The earnings beat and fresh client wins, including new agreements with Allspring, Saltus and Rareview Capital, come after a softer patch for the share price. The 30-day share price return shows an 11.09% decline and the...
NYSE:GMED
NYSE:GMEDMedical Equipment

How Globus Medical’s Robotics and Digitization Push Will Impact Globus Medical (GMED) Investors

In recent months, Globus Medical has drawn attention for pairing strong fundamentals and a debt-free balance sheet with rapid expansion in musculoskeletal-focused technologies, including its ExcelsiusGPS robotic-assisted surgery platform and new Excelsius XR headset. At the same time, the company’s extensive innovation pipeline and leadership in healthcare digitization are being weighed against pressures such as longer robotics sales cycles, integration work following past acquisitions, and...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

How Investors May Respond To Agilysys (AGYS) Raising Fiscal 2026 Revenue Guidance After Q3 Results

In January 2026, Agilysys, Inc. reported third-quarter fiscal 2026 results showing revenue of US$80.39 million and net income of US$9.9 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier. The company also raised its fiscal 2026 earnings guidance to US$318 million in total revenue, signaling management’s confidence in its operational performance so far this year. We’ll now examine how Agilysys’s raised fiscal 2026 revenue guidance...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Its Steep Share Price Declines And DCF Outlook

If you are wondering whether Recursion Pharmaceuticals' current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers suggest about value. The stock last closed at US$3.98, after share price returns of a 5.0% decline over 7 days, 14.6% decline over 30 days, 5.2% decline year to date, and 46.9% decline over the past year, with a 51.4% decline over three years. Recently, headlines around Recursion Pharmaceuticals have focused on its...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

Is DLocal (DLO) Pricing Look Interesting After Recent Share Price Weakness?

If you are wondering whether DLocal's current share price reflects its true worth, you are not alone. The stock raises some clear questions about value that are worth unpacking. DLocal recently closed at US$13.18, with returns of a 2.1% decline over 7 days, an 8.0% decline over 30 days, a 6.3% decline year to date, an 8.3% gain over the past year, and a 14.7% decline over 3 years. Recently, investors have been reacting to company specific news and broader sentiment around emerging market...
NYSE:RCL
NYSE:RCLHospitality

Assessing Royal Caribbean Cruises (RCL) Valuation After Earnings, Growth Guidance And Fleet Investment Plans

Why Royal Caribbean Cruises (RCL) Is Back in Focus Royal Caribbean Cruises (RCL) is back on investors’ radar after fourth quarter and full year 2025 earnings that met Wall Street expectations, new 2026 revenue guidance, fresh ship orders, and a completed share buyback. The company reported fourth quarter 2025 sales of US$1,323 million, compared with US$1,161 million a year earlier, on revenue of US$4,259 million versus US$3,761 million. Net income for the quarter was US$754 million, with...
NYSE:KVYO
NYSE:KVYOSoftware

Klaviyo (KVYO) Valuation Check As New ChatGPT Integration And Wunderkind Partnership Advance Its AI Roadmap

Klaviyo (KVYO) just rolled out its Klaviyo app in ChatGPT and welcomed Wunderkind to its App Marketplace, tying together AI driven marketing workflows and identity data in ways that could influence how investors view the stock. See our latest analysis for Klaviyo. Despite Klaviyo leaning further into AI with the new ChatGPT app and the Wunderkind partnership, the share price has pulled back to US$19.14, with a 30 day share price return of 33.03% and a 1 year total shareholder return declining...
NYSE:AFL
NYSE:AFLInsurance

A Look At Aflac (AFL) Valuation After Q4 Earnings Miss And Dividend Hike

Aflac (AFL) is back in focus after its fourth quarter 2025 earnings update, where lower net investment income and higher operating costs weighed on results, even as Japan sales, dividend growth, and buybacks attracted attention. See our latest analysis for Aflac. Despite the earnings miss, Aflac's recent news around dividend growth and heavy buybacks has come alongside a 7.2% 1 month share price return and a 15.6% 1 year total shareholder return. This suggests momentum has been building...
NasdaqGS:BL
NasdaqGS:BLSoftware

Is BlackLine (BL) Starting To Look Attractive After Prolonged Share Price Weakness

If you are wondering whether BlackLine is starting to look interesting at its current price, or why the stock has been marked down so much, this piece will help you frame that question through a clear valuation lens. BlackLine's share price closed at US$43.85, with returns of a 5.6% decline over 7 days, a 22.5% decline over 30 days, an 18.5% decline year to date, a 32.2% decline over 1 year, a 39.6% decline over 3 years, and a 67.1% decline over 5 years. These figures may affect how you...
NYSE:ALK
NYSE:ALKAirlines

Is Alaska Air Group (ALK) Pricing Reflect Recent Volatility And Rich Valuation Multiples

If you are wondering whether Alaska Air Group at around US$59.45 is a bargain or a value trap, starting with a clear view of its valuation can help frame your next move. The stock has recently been volatile, with a 17.0% return over the last 7 days and 18.9% over 30 days, compared with a 15.4% return year to date and a 21.7% decline over the past year, plus longer term returns of 19.9% over 3 years and 3.3% over 5 years. Recent news coverage around Alaska Air Group has focused on the company...
NasdaqGS:USLM
NasdaqGS:USLMBasic Materials

United States Lime & Minerals (USLM) Valuation After Strong 2025 Results And Dividend Declaration

Why United States Lime & Minerals is Back on Investors’ Radar United States Lime & Minerals (USLM) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with a new quarterly dividend declaration that highlights its current earnings power and cash returns policy. See our latest analysis for United States Lime & Minerals. The earnings release and dividend news follow a period of weaker share price performance, with a 30 day share price return showing a...
NasdaqGS:FLXS
NasdaqGS:FLXSConsumer Durables

Assessing Flexsteel Industries (FLXS) Valuation After Mixed Sales And Earnings In Latest Quarterly Update

Why Flexsteel’s latest earnings are drawing fresh attention Flexsteel Industries (FLXS) has caught investor attention after its latest quarterly update, where higher sales sat alongside lower quarterly net income and earnings per share, while the six month figures moved modestly higher on both counts. See our latest analysis for Flexsteel Industries. The latest earnings update has arrived alongside a sharp shift in sentiment. The share price is US$57.55, and a 90 day share price return of...
NYSE:INGR
NYSE:INGRFood

A Look At Ingredion (INGR) Valuation As Argo Disruptions Weigh On 2025 Results And 2026 Outlook

Ingredion (INGR) is back in focus after reporting softer fourth quarter 2025 sales, operational disruptions at its Argo facility, and cautious 2026 guidance that points to modest growth while Texture and Healthful Solutions continues to expand. See our latest analysis for Ingredion. Ingredion's recent guidance, Argo facility issues, and CFO retirement update come against a backdrop of a firm 90 day share price return of 11.8% and a 30 day share price return of 5.76%. The 1 year total...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

A Look At Selective Insurance Group (SIGI) Valuation After Strong Q4 2025 Earnings And Insider Buying

Selective Insurance Group (SIGI) is back on investors radar after reporting fourth quarter 2025 results that paired stronger underwriting with higher investment income, alongside fresh insider buying that underscores Board level confidence. See our latest analysis for Selective Insurance Group. The recent 7 day share price return of 7.16% and 90 day share price return of 14.67% suggest momentum has picked up following robust Q4 earnings, Board level by law updates, ongoing buybacks and steady...
NasdaqGS:PSMT
NasdaqGS:PSMTConsumer Retailing

A Look At PriceSmart (PSMT) Valuation As Dividend Increase Signals Confidence In Cash Generation

Dividend increase and what it means for PriceSmart shareholders PriceSmart (PSMT) has announced an 11.1% increase to its annual cash dividend, moving to US$1.40 per share for 2026, a change that puts income and capital allocation in clearer focus for investors. See our latest analysis for PriceSmart. The dividend news lands after a strong run in the shares, with a 90 day share price return of 35.9% and a 1 year total shareholder return of 73.3%. This hints that momentum has been building...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

ACM Research (ACMR) Valuation Check As China Quasi Monopoly And Cleaning Tools Draw Fresh Interest

Renewed attention on ACM Research (ACMR) is being driven by fresh commentary around its SAPS and TEBO cleaning tools, their role with leading memory makers, and how U.S. sanctions have affected competitors in China. See our latest analysis for ACM Research. The recent excitement around ACM Research’s cleaning tools sits alongside sharp market moves, with a 1 day share price return of 14.87% and a 90 day share price return of 89.62%. The 1 year total shareholder return of 174.52% and 3 year...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

A Look At Euronet Worldwide (EEFT) Valuation As Digital Growth Follows Earnings Miss And Short Seller Pressure

Euronet Worldwide (EEFT) is back in focus after a tough year marked by a 3Q25 earnings miss and short seller pressure, as digital money transfer transactions rose 32% year over year and margins expanded. See our latest analysis for Euronet Worldwide. The recent 4.4% 1 day share price return and 3.5% 7 day share price return to around $75.02 contrast with a 1 year total shareholder return decline of 22.6%. Short term momentum is improving while longer term holders remain under pressure as the...
NYSE:PB
NYSE:PBBanks

A Look At Prosperity Bancshares (PB) Valuation After Credit Concerns Temper Earnings Improvement

Why Prosperity Bancshares (PB) is back in focus Prosperity Bancshares (PB) landed back on investors’ radar after its latest quarterly results, where higher net interest income and earnings coincided with rising net charge-offs and growing concern around credit quality. The market reaction has been shaped by a mix of positives, such as deposit growth and cost control, and pressure points including increased nonperforming assets and softer loan balances that raised fresh questions about...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

Assessing CME Group (CME) Valuation After Record Results And New Crypto And Clearing Initiatives

Why CME Group’s latest earnings matter for shareholders CME Group (CME) just released fourth quarter and full year 2025 results, giving you fresh numbers on how the futures exchange operator is performing and where its growth engines currently sit. The company reported fourth quarter revenue of US$1,648.7 million and net income of US$1,182.9 million, with diluted earnings per share from continuing operations of US$3.24. For the full year, revenue was US$6,520.6 million and net income reached...
NYSE:CFR
NYSE:CFRBanks

Cullen/Frost (CFR) Deepens Capital Returns and Texas Expansion: Credible Growth Story or Peak Cycle?

Cullen/Frost Bankers recently reported fourth-quarter and full-year 2025 results showing higher net interest income and net income year over year, alongside board approval of continued common and preferred dividends and a new US$300 million share repurchase program. The company also refreshed its board with the addition of experienced executives Marsha M. Shields and Jeff Rummel, while highlighting Texas-focused branch expansion, strong organic customer growth, and historically high levels...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Assessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention

Why Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 months prompting investors to reassess the stock’s current pricing. See our latest analysis for Henry Schein. At a share price of US$79.72, Henry Schein has recently seen stronger short term momentum, with a 1 day share price return of 3.53% and a 90 day share price return of 9.21%, while the 1 year total...